Naver Cloud became the first South Korean cloud service provider to develop a gene data analysis platform.
The newly-developed Nvidia Clara Parabricks on the platform of Naver Cloud, an affiliate of South Korea’s leading internet portal operator Naver Corp., is the combination of the Naver Cloud server with US graphics chip giant Nvidia Corp.’s Clara Parabricks software suite.
Clara Parabricks is a system that uses huge graphic processing units to interpret gene data.
Naver Cloud plans to launch the Genome Analysis All-in-One Integrated Platform in its marketplace in the first half of this year, in conjunction with local personal genomics business ichrogene.
Beginning with the cooperation with Nvidia and ichrogene, Naver Cloud will continue to expand its presence in the gene analysis market, according to the company’s executive director, Han Sang-young.


U.S. Dollar Climbs as Trump Escalates Rhetoric Against Iran
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Oil Prices Slide as Iran Tensions Ease and U.S. Crude Stockpiles Swell
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Tabletop particle accelerator could transform medicine and materials science
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



